INDmoney
Aurobindo Pharma Share Price
₹1311.90
+7.10
(+0.54%)
as on
🔔 Regulatory News Alert
Aurobindo Pharma's Andhra Pradesh Unit-IV received USFDA's Voluntary Action Indicated (VAI) classification after inspection with five observations; inspection now closed.
Aurobindo Pharma Stock Performance
as on March 12, 2026 at 9:31 pm IST
Day's Low
Day's High
₹1,289.40₹1,319.80
1.72%
Downside
0.60%
Upside
52 Week's Low
52 Week's High
₹1,010.00₹1,319.8023.01%
Downside
0.60%
Upside
Aurobindo Pharma share price movements today
- Previous Close
- ₹1,304.80
- Open
- ₹1,308.00
- Volume
- 21.10L
- Upper Circuit
- ₹1,435.20
- Lower Circuit
- ₹1,174.40
- Day's Low - High
- ₹1,289.40 - ₹1,319.80
- 52 Week Low - High
- ₹1,010.00 - ₹1,319.80
Aurobindo Pharma Historical Returns
- 1 Month Return
- + 12.69 %
- 3 Month Return
- + 9.18 %
- 1 Year Return
- + 17.77 %
- 3 Year Return
- + 190.83 %
- 5 Year Return
- + 53.82 %
Aurobindo Pharma Fundamentals
as on March 12, 2026 at 4:01 pm IST
Market Cap
₹75,783.00 Cr
Return on Equity (ROE)
8.68
PE Ratio (TTM)
21.73
Return on capital employed (ROCE)
10.82
Industry PE ratio
42.52
Beta (LTM)
0.99
P/B Ratio
3.28
Dividend Yield
0PEG Ratio
77.61
Quarterly Earnings Growth YOY
7.6
EPS (TTM)
59.98
Sector
Pharmaceuticals
Book Value
562.21
Technical Analysis
Bullish
View Technical Analysis
Aurobindo Pharma Stock Valuation
as on March 12, 2026 at 4:01 pm IST
Aurobindo Pharma in the last 5 years
Lowest (6.73x)
March 23, 2020
Today (21.73x)
March 11, 2026
Industry (42.52x)
March 11, 2026
Highest (27.59x)
December 21, 2023
Today’s Price to Earnings Ratio: 21.73x
Aurobindo Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 75,783.00 | 10.76% | 0.60 | 3,483 | 31,723 | |
| BUY | 8,404.34 | -11.22% | 0.52 | 413 | 2,013 | |
| HOLD | 92,749.62 | 21.66% | 0.61 | 4,614 | 23,241 | |
| BUY | 57,800.00 | 17.22% | 0.00 | 1,414 | 6,445 | |
| BUY | 42,114.34 | 14.27% | 0.56 | 927 | 3,749 |
Market expectation of Aurobindo Pharma Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
80.77%
Buy
0.00%
Hold
19.23%
Sell
Aurobindo Pharma Stock’s Investor Sentiment and Interest
Investment in Aurobindo Pharma Ltd Shares on INDmoney has grown by 70.17% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:70.17% versus previous 30 day period
Search interest for Aurobindo Pharma Ltd Stock has increased by 97% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:97% versus previous 30 day period
Aurobindo Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Aurobindo Pharma Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds that own Aurobindo Pharma Stock
Check out the Mutual Funds with significant holdings in Aurobindo Pharma.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Mid Cap Fund -Direct Plan - Growth Option | 1.73% | 13344745 | |
 Quant ELSS Tax Saver Growth Option Direct Plan | 6.91% | 6710355 | |
Quant Mid Cap Fund Growth Option Direct Plan | 9.9% | 5969000 | |
 SBI Large & Midcap Fund Direct Growth | 1.7% | 5400000 | |
Quant Multi Cap Fund Growth Option Direct Plan | 6.96% | 4294483 |
Aurobindo Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Aurobindo Pharma.
Aurobindo Pharma Ltd Earnings Results
Aurobindo Pharma Ltd’s net profit jumped 7.62% since last year same period to ₹910.29Cr in the Q3 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 7.29% jump in its net profits since last 3-months.
Read More about Earnings ResultsAurobindo Pharma Ltd Dividends August,2025
In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.31%.
Read More about Dividends
Aurobindo Pharma News & Key Events
Today's Timeline - 12 March
05:04 PM
-Aurobindo Pharma's Unit-IV receives VAI classification from USFDA, closing the inspection conducted in December 2025.
Indices Featuring Aurobindo Pharma Stock
Check stock indices that include Aurobindo Pharma.
Insights on Aurobindo Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 824.75 Cr → 910.29 Cr (in ₹), with an average increase of 4.8% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 7.97K Cr → 8.83K Cr (in ₹), with an average increase of 5.0% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, AUROPHARMA stock has moved up by 6.5%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 19.30% to 19.52% in Dec 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 6.38% to 6.55% in Dec 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 43.1% return, outperforming this stock by 25.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.82% of holdings in Dec 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 193.7% return, outperforming this stock by 2.9%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 14.21% to 13.94% in Dec 2025 quarter
Aurobindo Pharma Stock Futures & Options Contracts
View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.
Aurobindo Pharma Options
Aurobindo Pharma Futures
About Aurobindo Pharma Ltd
The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.
Revenue: ₹8,604.51Cr as on December 2025 (Q3 FY26)
Net Profit: ₹909.80Cr as on December 2025 (Q3 FY26)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
| Organisation | Aurobindo Pharma Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K Ragunathan |
| E-voting on shares | Click here to vote |
FAQs
What is Aurobindo Pharma share price today?
Aurobindo Pharma share price today stands at ₹1311.9 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1319.8 and a low of ₹1289.4.
What is the 52 week high and 52 week low range for Aurobindo Pharma share?
Aurobindo Pharma touched a 52 week high of ₹1319.8 and a 52 week low of ₹1010. Aurobindo Pharma share price today i.e. is closed at ₹1311.9, which is -0.60% down from its 52 week high and 29.89% up from its 52 week low.
What is Aurobindo Pharma's market capitalisation today?
Aurobindo Pharma market capitalisation is ₹75,783.00 Cr as on .
How to buy Aurobindo Pharma shares?
To buy Aurobindo Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Aurobindo Pharma trading volume today?
Aurobindo Pharma trading volume is 21.10L as on . This means that 21.10L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.